03:37 PM EST - Cipher Pharmaceuticals Inc. : Announced its financial and operational results for the three months ended September 30, 2017. All figures are in U.S. currency. Total net revenue increased 29% to $10.1 million, from $7.8 million in Q3 2016. Income from continuing operations of $3.9 million, or $0.15 per basic share, compared with income from continuing operations of $2.2 million, or $0.08 per basic share, in Q3 2016. Cipher Pharmaceuticals Inc.
shares T.CPH are trading up $0.06 at $4.56.
